CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
Intratumoral distribution and pharmacokinetics of the radiolabeled ICAM-1 targeting monoclonal antibody R6.5 in a prostate cancer mouse model
DOI 10.1055/a-2543-0723
Bibliografische Angaben
Nachweis in CareLit
Autor:innenAnders Örbom, Susan Evans-Axelsson, Bo Jansson, Oskar Vilhelmsson Timmermand, Thuy A. Tran, Anders Bjartell, Sven-Erik Strand
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe02/2025
Jahrgang / SeitenJg. 64 · S. 163-169
Kernaussage aus der Literatur
Abstract-Vorschau
Abstract Aim Despite new therapies, castration-resistant prostate cancer (CRPC) is still incurable. Intercellular Adhesion Molecule 1 (ICAM-1) is a well-characterized cell surface protein involved in prostate cancer pathogenesis, differentially expressed during transition from hormone-sensitive to CRPC. This study aimed to investigate ICAM-1 as a target for imaging and radioimmunotherapy of CRPC. Methods Anti-ICAM-1…
Zitieren
Zitierempfehlung
Anders Örbom, Susan Evans-Axelsson, Bo Jansson, Oskar Vilhelmsson Timmermand, Thuy A. Tran, Anders Bjartell, Sven-Erik Strand (2025) Intratumoral distribution and pharmacokinetics of the radiolabeled ICAM-1 targeting monoclonal antibody R6.5 in a prostate cancer mouse model. Nuklearmedizin - NuclearMedicine, 64 (02), 163-169. https://doi.org/10.1055/a-2543-0723
Mit CareLit weiterarbeiten